Metropolis Healthcare has filed draft red herring prospectus (DRHP) with the market regulator Securities and Exchange Board of India (SEBI) to raise funds through an initial public offering (IPO). The IPO is of up to 1,52,69,684 equity shares, consisting an offer for sale of up to 50,17,868 equity shares by Sushil Kanubhai Shah and up to 1,02,51,816 equity shares by CA Lotus Investments.
The objects of the offer are to achieve the benefits of listing the equity shares on the stock exchanges and for the offer for sale. The book running lead managers to the issue are JM Financial, Credit Suisse Securities (India), Goldman Sachs (India), HDFC Bank and Kotak Mahindra Capital Company. The company’s shares are proposed to be listed on the BSE and NSE.
Metropolis Healthcare offers a comprehensive range of clinical laboratory tests and profiles, which are used for prediction, early detection, diagnostic screening, confirmation and/or monitoring of the disease.
Company Name | CMP |
---|---|
Apollo Hospital Ent. | 7236.35 |
Max Healthcare Inst | 1193.20 |
Narayana Hrudayalay | 1280.95 |
Aster DM Healthcare | 494.95 |
Global Health | 1133.80 |
View more.. |